Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Allison Transmission
ALSN
$10.3B
| $227M | 0.2% |
6,167,919
+774,500
| +14% | +$27.7M |
|
102
Duke Energy
DUK
$96.1B
| $222M | 0.19% |
2,781,964
-4,296,468
| -61% | -$363M |
|
103
Seagate
STX
$186B
| $221M | 0.19% |
4,574,629
-1,352,501
| -23% | -$67.9M |
|
104
Ryanair
RYAAY
$30.8B
| $214M | 0.18% |
8,070,520
-184,750
| -2% | -$4.68M |
|
105
Snap
SNAP
$9.32B
| $209M | 0.18% |
8,902,400
+5,971,100
| +204% | +$106M |
|
106
Peloton Interactive
PTON
$2.46B
| $209M | 0.18% |
3,618,800
+3,412,261
| +1,652% | +$141M |
|
107
JPMorgan Chase
JPM
$962B
| $207M | 0.18% |
2,204,786
+538,600
| +32% | +$51.1M |
|
108
Ericsson
ERIC
$33B
| $207M | 0.18% |
22,281,829
-6,977,971
| -24% | -$60.6M |
|
109
Fortis
FTS
$28.6B
| $206M | 0.18% |
5,408,097
+580,292
| +12% | +$22.1M |
|
110
Datadog
DDOG
$88.6B
| $204M | 0.18% |
2,349,100
+1,801,400
| +329% | +$110M |
|
111
Progressive
PGR
$123B
| $204M | 0.18% |
2,542,582
-1,819,286
| -42% | -$142M |
|
|
KL
112
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $203M | 0.18% |
4,923,334
+322,540
| +7% | +$12.5M |
|
|
ADSW
113
DELISTED
Advanced Disposal Services Inc
ADSW
| $200M | 0.17% |
6,627,818
+1,574,058
| +31% | +$50.2M |
|
114
American Electric Power
AEP
$67.3B
| $199M | 0.17% |
2,493,622
-3,036,518
| -55% | -$248M |
|
115
Medtronic
MDT
$116B
| $197M | 0.17% |
2,144,141
+1,959,245
| +1,060% | +$188M |
|
116
Gen Digital
GEN
$17.4B
| $196M | 0.17% |
9,907,138
+7,864,600
| +385% | +$160M |
|
117
Haemonetics
HAE
$3.97B
| $196M | 0.17% |
2,187,785
+3,400
| +0.2% | +$343K |
|
118
Bilibili
BILI
$7.53B
| $194M | 0.17% |
4,187,150
+92,600
| +2% | +$3.01M |
|
119
BP
BP
$111B
| $194M | 0.17% |
8,304,093
-5,600,300
| -40% | -$134M |
|
120
Take-Two Interactive
TTWO
$46.8B
| $189M | 0.16% |
1,354,440
+956,290
| +240% | +$125M |
|
121
Uber
UBER
$160B
| $187M | 0.16% |
+6,030,316
| New | +$188M |
|
122
lululemon athletica
LULU
$14.3B
| $186M | 0.16% |
595,814
-300,500
| -34% | -$76.8M |
|
123
Gold Fields
GFI
$36B
| $186M | 0.16% |
19,752,400
-725,000
| -4% | -$5.49M |
|
|
K
124
DELISTED
Kellanova
K
| $185M | 0.16% |
2,984,627
-673,080
| -18% | -$40.7M |
|
|
ATVI
125
DELISTED
Activision Blizzard
ATVI
| $181M | 0.16% |
2,388,898
+1,624,000
| +212% | +$113M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.